ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
VanEck Biotech ETF
232.02
+2.63
1.15%
成交量:
4,581
成交額:
105.91萬
市值:
4.66億
市盈率:
- -
高:
232.10
開:
230.06
低:
229.59
收:
229.39
52周最高:
244.35
52周最低:
160.91
股本:
200.65萬
流通股本:
200.65萬
量比:
0.48
換手率:
0.23%
股息:
0.95
股息率:
0.41%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
Vertex將以100億美元收購Crinetics
路透中文
·
07/07
Crinetics與福泰製藥交易預計2029年提升後者非GAAP運營收入
美股速递
·
07/07
Crinetics Pharmaceuticals:融資獲美國銀行與摩根士丹利的45億美元全額承諾過橋貸款支持
美股速递
·
07/07
福泰製藥就囊性纖維化療法Alyftrek與泛加拿大藥品聯盟簽署意向書
美股速递
·
07/06
再生元製藥公司預計2026年第二季度GAAP及非GAAP每股攤薄收益將減少1美元——SEC文件披露
美股速递
·
07/06
美國研究綜述-東西銀行、第一公民銀行控股公司、UMB
路透中文
·
07/06
禮來與再生元製藥公司入選FDA首批加速新生產設施審查計劃
投资观察
·
07/06
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BBH/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":232.024,"timestamp":1789416000000,"preClose":229.3922,"halted":0,"volume":4581,"delay":0,"changeRate":0.011472927152710503,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"盤前交易","change":2.6318,"latestTime":"09-15 08:52:49 EDT","open":230.06,"high":232.1,"low":229.5938,"amount":1059133.20111,"amplitude":0.010925,"askPrice":265.43,"askSize":100,"bidPrice":199.52,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":232.024,"sharesOutstanding":1976503,"nav":229.3061,"aum":460103384.52,"dividendRate":0.0041,"bidAskSpread":0.001038,"postHourTrading":{"tag":"盘后","latestPrice":231.9013,"preClose":232.024,"latestTime":"19:30 EDT","volume":18,"amount":4175.136,"timestamp":1789428602348,"change":-0.1227,"changeRate":-0.000529,"amplitude":0},"volumeRatio":0.4826983051476247,"impliedVol":0.187,"impliedVolPercentile":0.376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4826983051476247,"shares":2006503,"dividePrice":0.9513,"high":232.1,"amplitude":0.010925,"preClose":229.3922,"low":229.5938,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":232.024,"eps":0,"divideRate":0.0041,"volume":4581,"delay":0,"ttmEps":0,"open":230.06,"prevYearClose":189.2649,"prevWeekClose":229.3922,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":241.1222,"twentyDayClose":218.0411,"sixtyDayClose":188.0998},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649679469","title":"Vertex將以100億美元收購Crinetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679469","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679469?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:08","pubTimestamp":1783368527,"startTime":"0","endTime":"0","summary":"Vertex将以100亿美元收购Crinetics路透7月6日-Vertex Pharmaceuticals(VRTX.O)将以约100亿美元的总股权价值收购Crinetics Pharmaceuticals(CRNX.O),两家公司周一宣布了这一消息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4S4381BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU2236285917.USD","SG9999013999.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE00B19Z3B42.SGD","LU1035775433.USD","LU1585245621.USD","LU1674673691.USD","VRTX","BK4532","LU0256863811.USD","BK4588","BK4567","LU2324357040.USD","LU0417517546.SGD","IBBQ","LU0289739699.SGD","BIB","LU0058720904.USD","LU0109394709.USD","LU2362540622.SGD","IE00B19Z9P08.USD","IE0002141913.USD","BK4139","IE0002270589.USD","LU1778281490.HKD","LU0432979614.USD","LU2456880835.USD","LU1069344957.HKD","CRNX","LU0061475181.USD","IE00BZ9MQY76.HKD","IBB","LU0823416689.USD","LU2417539215.USD","LU2462157665.USD","BBH","LU1674673428.USD","IE00B894F039.SGD","BK4585","PBE","SG9999001176.SGD","IDNA","LU0889565916.HKD","LU0079474960.USD","IE00B2B36J28.USD","LU2237438978.USD","LU1093756325.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833937","title":"Crinetics與福泰製藥交易預計2029年提升後者非GAAP運營收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127833937?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:07","pubTimestamp":1783368452,"startTime":"0","endTime":"0","summary":"根据最新披露的财务预测,Crinetics Pharmaceuticals Inc. 与福泰制药达成的战略合作,预计将在2029年对福泰制药的非通用会计准则运营收入产生积极贡献。\n此次交易的结构设计旨在通过长期协同效应,增强福泰制药的盈利质量。分析指出,该合作不仅将拓展福泰制药在特定治疗领域的产品管线,还可能优化其整体运营效率。市场预期,随着合作项目进入成熟阶段,其对财务指标的正面影响将逐步显现。\n财务模型显示,此次合作带来的收入增长与成本协同效应,是推动非通用会计准则运营收入提升的关键因素。投资者正密切关注交易细节及后续整合进程,以评估其长期价值创造潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4533","LU2456880835.USD","BK4567","LU1674673428.USD","LU0079474960.USD","LU2462157665.USD","IBB","SG9999001176.SGD","LU0320765992.SGD","LU0061475181.USD","BK4588","LU0432979614.USD","LU1093756168.USD","BK4585","IBBQ","LU1778281490.HKD","LU2236285917.USD","LU2362541273.HKD","LU1585245621.USD","IE00B19Z3581.USD","LU0823416689.USD","IE0002141913.USD","LU0417517546.SGD","IE00B4R5TH58.HKD","LU1069344957.HKD","LU0289739699.SGD","IDNA","IE00B2B36J28.USD","VRTX","IE00BZ9MQY76.HKD","LU1674673691.USD","IE0002270589.USD","LU2362541513.USD","IE00B19Z9Z06.USD","LU0109394709.USD","LU1430594728.SGD","LU0889565916.HKD","LU2237438978.USD","BBH","IE00B894F039.SGD","PBE","BIB","LU0058720904.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","LU0234570918.USD","IE00B19Z3B42.SGD","LU1093756325.SGD","SGXZ57979304.SGD","SG9999001176.USD","LU1035775433.USD","CRNX","LU0256863811.USD","LU2362540622.SGD","BK4532","IE0009355771.USD","IE00B19Z9P08.USD","BK4139","LU2417539215.USD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179291339","title":"Crinetics Pharmaceuticals:融資獲美國銀行與摩根士丹利的45億美元全額承諾過橋貸款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179291339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179291339?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 04:06","pubTimestamp":1783368378,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 的融资计划,已获得来自美国银行和摩根士丹利高级融资部门提供的总额高达45亿美元的全额承诺过桥贷款支持。这笔资金将为公司的战略推进提供坚实的财务后盾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","SG9999013999.USD","LU0889565916.HKD","LU1035775433.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU2456880835.USD","IE0009355771.USD","LU1069344957.HKD","IE0002270589.USD","LU0432979614.USD","LU0256863811.USD","IE00B19Z3B42.SGD","IE00B894F039.SGD","LU1674673691.USD","LU2324357040.USD","LU2362541273.HKD","IE00BZ9MQY76.HKD","LU2237438978.USD","BK4533","BK4532","LU0234570918.USD","LU1778281490.HKD","LU0320765992.SGD","LU2362540622.SGD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU1430594728.SGD","LU2362541513.USD","VRTX","BK4139","SG9999001176.USD","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU1585245621.USD","IE00B4R5TH58.HKD","IE00B19Z3581.USD","LU0061475181.USD","BBH","IDNA","IBB","LU0058720904.USD","IE00B2B36J28.USD","LU0079474960.USD","LU1093756168.USD","LU1674673428.USD","PBE","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","LU0109394709.USD","CRNX","LU2417539215.USD","BK4585","SGXZ57979304.SGD","LU0823416689.USD","IE0002141913.USD","BK4588","LU0289739699.SGD","BK4007","BK4567","BIB","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154393441","title":"福泰製藥就囊性纖維化療法Alyftrek與泛加拿大藥品聯盟簽署意向書","url":"https://stock-news.laohu8.com/highlight/detail?id=1154393441","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154393441?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 22:25","pubTimestamp":1783347947,"startTime":"0","endTime":"0","summary":"福泰制药与泛加拿大药品联盟就囊性纤维化治疗药物Alyftrek的潜在合作签署了意向书。此举标志着该药物在加拿大市场准入进程中的一个重要步骤,旨在为患者提供新的治疗选择。意向书的签署为后续正式协议的谈判奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","SG9999013999.USD","LU0889565916.HKD","LU1035775433.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU2456880835.USD","IE0009355771.USD","LU1069344957.HKD","IE0002270589.USD","LU0432979614.USD","LU0256863811.USD","IE00B19Z3B42.SGD","IE00B894F039.SGD","LU1674673691.USD","LU2324357040.USD","LU2362541273.HKD","IE00BZ9MQY76.HKD","LU2237438978.USD","BK4533","BK4532","LU0234570918.USD","LU1778281490.HKD","LU0320765992.SGD","LU2362540622.SGD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU1430594728.SGD","LU2362541513.USD","VRTX","BK4139","SG9999001176.USD","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU1585245621.USD","IE00B4R5TH58.HKD","IE00B19Z3581.USD","LU0061475181.USD","BBH","IDNA","IBB","LU0058720904.USD","IE00B2B36J28.USD","LU0079474960.USD","LU1093756168.USD","LU1674673428.USD","PBE","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","LU0109394709.USD","LU2417539215.USD","BK4585","SGXZ57979304.SGD","LU0823416689.USD","IE0002141913.USD","BK4588","LU0289739699.SGD","LU2236285917.USD","BK4567","BIB","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132494711","title":"再生元製藥公司預計2026年第二季度GAAP及非GAAP每股攤薄收益將減少1美元——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1132494711","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132494711?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 19:03","pubTimestamp":1783335796,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会(SEC)的文件,再生元制药公司(Regeneron Pharmaceuticals)预计,其2026年第二季度的美国通用会计准则(GAAP)及非美国通用会计准则(Non-GAAP)每股摊薄收益将出现下降,减少幅度约为1美元。这一预期反映了公司在特定时期内的财务表现可能面临的调整或挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0889565916.HKD","LU2237438978.USD","LU0053666078.USD","IBBQ","LU0823416689.USD","LU0114720955.EUR","LU2362540622.SGD","LU2106854487.HKD","BK4588","LU0289739699.SGD","LU2023250504.SGD","LU0882574055.USD","LU2362541513.USD","LU2468319806.SGD","LU0823434740.USD","BK4139","LU0823434583.USD","LU2089984988.USD","REGN","LU0109394709.USD","BK4585","LU1917777945.USD","LU0320765992.SGD","LU2362541273.HKD","LU1974910355.USD","LU0058720904.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649644013","title":"美國研究綜述-東西銀行、第一公民銀行控股公司、UMB","url":"https://stock-news.laohu8.com/highlight/detail?id=2649644013","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649644013?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 16:22","pubTimestamp":1783326173,"startTime":"0","endTime":"0","summary":"美国研究综述-东西银行、第一公民银行控股公司、UMB路透7月6日-周一,华尔街证券分析师下调了多家在美国上市公司的评级和目标股价,其中包括东西银行、第一公民银行控股公司和UMB金融公司。股票条目按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4S4380GO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBLS","BBH","FCNCA","IQV","PNFP","ADP","EROC","AGNG","CFR","ZTS","PJP","DLTR","MEDI","UNHG","OZK","JNJ","XLV","ABBV","CCB","FLG","IHE","WTFC","FRBT","OZEM","USB","DFNL","CVS","PAWZ","UNH","HBAN","ZION","IBB","EWBC","MRK","NEMG","AGMI","FTXH","PFE","QABA","CBSH","UNHW","NEM","BIIB","SOC","RGLD","GILD","IHF","EKG","UMBF","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142675479","title":"禮來與再生元製藥公司入選FDA首批加速新生產設施審查計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1142675479","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142675479?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 15:15","pubTimestamp":1783322114,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)近日启动了一项旨在加速新生产设施审查的倡议,而制药巨头礼来与再生元制药公司成为首批入选该计划的企业。此举旨在通过优化监管流程,缩短创新药物生产设施从建设到获批投产的时间,从而更快地将关键疗法推向市场。\n对于礼来和再生元而言,参与此计划意味着其未来新建或扩建的生产基地可能获得FDA更优先、更高效的审查。在当前全球生物制药竞争日益激烈的背景下,提升产能布局的敏捷性至关重要,尤其是在糖尿病、肥胖症、癌症及炎症性疾病等需求旺盛的治疗领域。这一监管合作模式有望成为行业加速发展的新催化剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203201768.USD","LU2264538146.SGD","IE0005OL40V9.USD","LU2028103732.USD","LU0109394709.USD","LU2237443978.SGD","LU0323591593.USD","LU2168564222.USD","SG9999001176.USD","MEDX","IE00B4JS1V06.HKD","LU2362541513.USD","LU0053666078.USD","LU2237443382.USD","LU1267930730.SGD","LU1720051017.SGD","LU2168564065.EUR","LU0234572021.USD","LU2491050154.USD","PPH","IE00BJJMRZ35.SGD","SG9999015986.USD","SG9999015952.SGD","LU0238689110.USD","IBB","LU1093756325.SGD","LU1804176565.USD","CURE","LU2023250330.USD","LU2746668461.USD","LU0417517546.SGD","IE00BJJMRY28.SGD","ILDR","LU0096364046.USD","BBH","AGNG","LU1291159041.SGD","SG9999017495.SGD","SG9999018857.SGD","LU2471134879.HKD","THNR","LU2213496289.HKD","LU2461242641.AUD","SG9999015978.USD","LU0471298694.HKD","LU2324357040.USD","LU1623119135.USD","LU1974910355.USD","LU2168563687.JPY","IE00BN29S564.USD","LU2552382058.USD","LU2211815571.USD","IE0002141913.USD","LU0820561818.USD","LU1035775433.USD","LU2089284900.SGD","LU2756315318.SGD","LU0354030511.USD","IE0001KFT4U8.USD","LU2237438978.USD","LU2417539215.USD","WDNA","LU0353189680.USD","BK4533","LU0786609619.USD","LU0109391861.USD","LU0198837287.USD","LU0354030438.USD","LU0882574139.USD","BK4007","LU1548497426.USD","LU0133085943.USD","LU0079474960.USD","LU0106261372.USD","LU1868837300.USD","LU2491050071.SGD","LU2357305700.SGD","IE00BJLML261.HKD","LU0882574055.USD","LU1064131342.USD","LU1551013342.USD","LU1720051108.HKD","LU2746668974.SGD","LU0385154629.USD","SG9999014906.USD","LU0823434583.USD","LU0689472784.USD","LU2023251221.USD","IE0004445239.USD","CANC","IBBQ","LU2237443622.USD","SG9999014880.SGD","LU1145028129.USD","LU1232071149.USD","LU2106854487.HKD","LU2265009873.SGD","LU2552382132.HKD","IE00BJJMRX11.SGD","LU0345770308.USD","LU1629891620.HKD","LU0225283273.USD","LU0471298777.SGD","IYH","LU0672654240.SGD","LU2087625088.SGD","LU2362540622.SGD","LU0640476718.USD","LU2089984988.USD","SGXZ51526630.SGD","FHLC","IE00BKDWB100.SGD","LU2471134952.CNY","XLV","LU0256863902.USD","BK4534","IE0009355771.USD","IE00B4R5TH58.HKD","HRTS","LU2236285917.USD","SGXZ99366536.SGD","SGXZ81514606.USD","ELIL","LU1712237335.SGD","LU1868836914.USD","IE00BFSS7M15.SGD","LU2023250504.SGD","LU0158827948.USD","LU1069344957.HKD","LU1988902786.USD","LU2089283258.USD","LU2111349929.HKD","SG9999001176.SGD","LU0058720904.USD","LU0158827781.USD","LU2063271972.USD","LU0122379950.USD","LU1917777945.USD","IE00BFSS8Q28.SGD","LU1323610961.USD","SG9999013999.USD","LU0943347566.SGD","SGXZ57979304.SGD","IE00B1BXHZ80.USD","LU2112291526.USD","IE00BWXC8680.SGD","IHE","LU0320765992.SGD","BK4588","LU0210536198.USD","LU2552382215.SGD","LU0345770993.USD","LU2896262040.SGD","LU0964807845.USD","LU1989771016.USD","GB00BDT5M118.USD","LLII","LU0114720955.EUR","LU1868836757.USD","LU1023059063.AUD","LU2491049909.HKD","LU2750360997.AUD","LU0889565916.HKD","LU2750360641.GBP","LU1127390331.HKD","LU1280957306.USD","LU0097036916.USD","IE00B775H168.HKD","LU1983299246.USD","LU2360106947.USD","LU1061106388.HKD","LU0061475181.USD","LU2108987350.USD","BK4599","LU2271345857.HKD","IE00BK4W5L77.USD","IE00BKPKM429.USD","LU0683600562.USD","LLYZ","LU1868836591.USD","LU2237443895.HKD","LU2602419157.SGD","LU0094547139.USD","LU0203202063.USD","LU2168564149.EUR","PJP","LU0266013472.USD","LU0432979614.USD","LU2361044865.SGD","IXJ","BK4581","LU2361045086.USD","OZEM","IE00BFTCPJ56.SGD","JDOC","LU1814569148.SGD","REGN","LU2468319806.SGD","RXL","LU0256863811.USD","IE00B7KXQ091.USD","LU2456880835.USD","LU2361044949.HKD","IE00B1XK9C88.USD","LLYX","LU0316494557.USD","SG9999014914.USD","LU2362541273.HKD","LU2168564495.EUR","LU2471134796.USD","ELIS","LU0823434740.USD","LU1366192091.USD","LLY","SG9999015945.SGD","LU2237443549.SGD","BK4139","LU2237443465.HKD","LU1551013425.SGD","MEDI","IE0004445015.USD","LU0006306889.USD","LU0708995401.HKD","LU0787776722.HKD","LU0353189763.USD","SGXZ31699556.SGD","LU0820561909.HKD","LU0289739699.SGD","LU2462157665.USD","LU0456855351.SGD","LU1868837136.USD","LU1057294990.SGD","LU0320765059.SGD","BK4516","VHT","FTXH","LU0820562030.AUD","LU0823416689.USD","BK4585","IE00BJT1NW94.SGD","SG9999014898.SGD","IE00B2B36J28.USD","SG9999018865.SGD","LU2471134523.USD","LU2756315664.SGD","IE00BK4W5M84.HKD","GDOC","LU1093756168.USD","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":187,"code":"91000000","status":"200"}]}}